Complication Registry for Tonsil Surgery
Condition(s):Tonsillar Surgery ComplicationsLast Updated:February 3, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Tonsillar Surgery ComplicationsLast Updated:February 3, 2014Completed
Condition(s):Eye Diseases Hereditary; Retinal Disease; Achromatopsia; Bardet-Biedl Syndrome; Bassen-Kornzweig Syndrome; Batten Disease; Best Disease; Choroidal Dystrophy; Choroideremia; Cone Dystrophy; Cone-Rod Dystrophy; Congenital Stationary Night Blindness; Enhanced S-Cone Syndrome; Fundus Albipunctatus; Goldmann-Favre Syndrome; Gyrate Atrophy; Juvenile Macular Degeneration; Kearns-Sayre Syndrome; Leber Congenital Amaurosis; Refsum Syndrome; Retinitis Pigmentosa; Retinitis Punctata Albescens; Retinoschisis; Rod-Cone Dystrophy; Rod Dystrophy; Rod Monochromacy; Stargardt Disease; Usher SyndromeLast Updated:February 15, 2023Recruiting
Condition(s):ColoRectal CancerLast Updated:June 29, 2020Unknown status
Condition(s):Breast Cancer; Chronic Fatigue SyndromeLast Updated:October 20, 2022Recruiting
Condition(s):Intensive Care (ICU) PatientsLast Updated:April 4, 2018Completed
Condition(s):Cardiac Rehabilitation; Acute Coronary SyndromeLast Updated:January 26, 2022Unknown status
Condition(s):Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency; Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy); Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations); Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan); Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan and Epilepsy); Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C)); Alpha-Dystroglycanopathy (Fukuyama CMD); Alpha-Dystroglycanopathy (LGMDR09 FKRP Related (Formerly LGMD2I)); Alpha-Dystroglycanopathy (LGMDR11 POMT1 Related (Formerly LGMD2K)); Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M)); Alpha-Dystroglycanopathy (LGMDR14 POMT2 Related (Formerly LGMD2N)); Alpha-Dystroglycanopathy (LGMDR15 POMGnT1 Related (Formerly LGMD2O)); Alpha-Dystroglycanopathy (LGMDR19 GMPPB Related (Formerly LGMD2T)); Alpha-Dystroglycanopathy (LGMDR20 ISPD Related (Formerly LGMD2U)); Alpha-Dystroglycanopathy (LGMDR24 POMGnT2 Related); Alpha-Dystroglycanopathy (Muscle Eye Brain Disease (MEB)); Alpha-Dystroglycanopathy (Walker Warburg Syndrome (WWS)); Choline Kinase B Receptor – CHKB; Collagen VI Related Disorders; Collagen XII Related Disorders; Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive); Congenital Muscular Dystrophy With Cataracts and Intellectual Disability (MDCCAID); Congenital Muscular Dystrophy With Joint Hyperlaxity; Congenital Muscular Dystrophy With Rigid Spine Related to ACTA1; Emery-Dreifuss Muscular Dystrophy; GOLGA2-related Congenital Muscle Dystrophy With Brain Involvement; LMNA Related Disorders; Merosin Deficient CMD (Full or Partial); Nesprin Related MD (SYNE1); SELENON Related Disorders (Previously Known as SEPN1); SELENON Related Myopathy (Aka SEPN1); Telethonin CMD; Congenital Myasthenic Syndrome; Limb-Girdle Muscular Dystrophy; LGMDD01 – DNAJB6 (Formerly LGMD1D); LGMDD05 – Collagen VI Related Bethlem Myopathy (Dominant); LGMDR07 – Telethonin (TCAP) Related (Formerly LGMD2G); LGMDR08 – TRIM Related (Formerly LGMD2H); LGMDR09 – FKRP Related (Formerly LGMD2I); LGMDR10 – Titin (TTN) Related (Formerly LGMD2J); LGMDR11 – POMT1 Related (Formerly LGMD2K); LGMDR13 – Fukutin (FKTN) Related (Formerly LGMD2M); LGMDR14 – POMT2 Related (Formerly LGMD2N); LGMDR15 – POMGnT1 Related (Formerly LGMD2O); LGMDR16 – DAG1 Related Dystroglycanopathy (Formerly LGMD2P); LGMDR17 – Plectin (PLEC) Related (Formerly LGMD2Q); LGMDR18 – TRAPPC11 Related (Formerly LGMD2S); LGMDR19 – GMPPB Related (Formerly LGMD2T); LGMDR20 – ISPD Related (Formerly LGMD2U); LGMDR22 – Collagen VI Related Bethlem Myopathy (Recessive); LGMDR23 – LAMA2 Related; LGMDR24 – POMGnT2 RelatedLast Updated:August 9, 2021Recruiting
Condition(s):Organ Donation; Donor Designation/RegistrationLast Updated:May 1, 2020Completed
Condition(s):Cardio Respiratory ArrestLast Updated:July 29, 2020Completed
Condition(s):Chronic PainLast Updated:January 31, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.